Delivery Order 75N95025D00007-75N95025F00003

Award Date 7/23/25
Potential Completion Date 5/14/30
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The contract, valued at $416,591.00, is for the NIDA Pharmacokinetic Analysis Resource Center, with a period of performance from September 1, 2020 to October 31, 2025. It is a delivery order contract with a cost-plus-fixed-fee pricing type. The contract was not set...
This is a delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The $415,717.00 contract is for a Phase I Single Ascending Dose Study under NIDA's Pharmacokinetic Analysis Resource Center program. The work will be performed in Westlake, Maryland from September 10, 2024 to March 9, 2026. This contract is not set aside and is a...
This federal contract award, valued at $2,701,936.00, was issued by the National Institute on Drug Abuse (NIDA) to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The contract, which is not set aside, provides ACTIV-1 time-limited biospecimen storage and related services related to COVID-19, as well as optional services including statistical support, biospecimen analysis, regulatory support, and governance logistics...
This is a $442,380.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc., a minority-owned, woman-owned, and Hispanic American-owned small business. The contract is for a Pharmacokinetic Analysis Resource Center to conduct a Phase I single ascending dose study from May 15, 2025 to November 14, 2026. This task order is part of a larger $545.4 million single-award Indefinite Delivery...
This federal contract award is for the provision of other support services to the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), under the Department of Health and Human Services. The contract was awarded to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The contract has a potential value of $3,688.66 and is a Cost Plus Fixed Fee Delivery Order. It does...
This federal contract award, valued at $28,434.00, was issued by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, and Hispanic American-owned small business. The contract supports the NIDA Pharmacokinetic Analysis Resource Center under NIDA Reference No. N01DA-19-8947, with a completion date of February 9, 2025. Technical Resources...
This federal contract award with ID 75N95019D00009|75N95019F00088 was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The purpose of this $268,664 cost-plus-fixed-fee delivery order is to conduct a Phase I study of a CBD-morphine drug-drug interaction, as outlined in the contractor's proposal. This award is not designated as a...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a Cost Plus Fixed Fee Delivery Order contract worth $2,676,372.00 to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The contract is for DAIDS Quality Assurance, Quality Control and Inspection Readiness Support Services under Task Area F of the CARRRP contract vehicle. TRI has significant experience supporting biomedical research...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, and Hispanic American-owned small business. The contract is for a Pharmacokinetic Analysis Resource Center to conduct a Phase I clinical pharmacology/pharmacokinetic study from July 23, 2025 to January 22, 2026. The contract has a ceiling value of $11,079.00 and is not...
This $2,563,375.63 Delivery Order was awarded by the National Institutes of Health (NIH) National Library of Medicine to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business, to provide services for the Hazardous Substance Data Bank. The contract is part of TRI's $545 million National Institute of Allergy and Infectious Diseases (NIAID) Comprehensive Acquisition for Research and Research-Related Products and Services (CARRRP)...
  • 75N95025D00007
    Indefinite Delivery Contract
  • 75N95025D00007-75N95025F00003
    Delivery Order

This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The $36,099 task order is for providing other support services to the Pharmacokinetic Analysis Resource Center. The contract is a cost-plus-fixed-fee delivery order with a period of performance from July 23, 2025 to July 22, 2026, and a total potential value of $36,099. TRI has several indefinite delivery vehicle (IDV) contracts with NIDA and other federal health agencies, demonstrating the company's expertise in supporting complex medical research programs across multiple agencies. The contract was not set aside.

Generated 7/17/25, 2:31 PM